The Medical Device Business Journal — Medical Device News & Articles | MassDevice
Neoprobe Corp. (OTC:NEOP) hired a biotechnology and pharmaceuticals industry veteran as its chief development officer.
Mark Pykett, 46, is stepping into the role, which calls for him to assist the company with its product and business development, partnering and investor relations efforts, according to a press release from the Dublin, Ohio-based firm.
The first half of 2010 has been brutal for pharmaceutical sales representatives. There are hordes of former pharma sales representatives on the street, seeking new job opportunities. Many try to seek higher ground in the medical device industry, often with limited success.
There is a persistent stigma that pharmaceutical sales representatives cannot succeed as medical device reps. Some of the perceptions that contribute to this are:
By Mary Vanac
Great Lakes Pharmaceuticals Inc. closed a $3.1 million Series B equity offering led by Charter Life Sciences, the Palo Alto, Calif.-based venture capital firm with an office in Cincinnati.
The company, formed by Case Western Reserve University, University Hospitals Case Medical Center and Ricerca Biosciences LLC in 2005, plans to use the investment to complete a pivotal clinical study of B-Lock, its anti-microbial catheter lock solution.
By Chris Seper
Three Pennsylvania companies — a diagnostics business, an imaging company and another creating a treatment for head lice — were among nine businesses to receive a share of $1.8 million from Ben Franklin Technology Partners of Southeastern Pennsylvania.
The proposed merger between WuXi PharmaTech (Cayman) Inc. (NYSE:WX) and Charles River Laboratories International Inc. (NYSE:CRL) hit another snag after the Federal Trade Commission asked both companies for more information on the deal.
The request, detailed in a pair of regulatory filings, involves the viral clearance services, cell line characterization services and lot release testing services businesses of both companies
SurModics Inc. (NSDQ:SRDX) reached a deal to license its drug delivery technology to an Australian firm that will use it for a skin disorder treatment.
PharmacoPhotonics Inc. raised $1.5 million in equity to develop a device that measures kidney function.
The company’s device can provide a measure of the kidney’s function, or glomerular filtration rate, in 15 to 30 minutes. Current methods of determing GFR either provide a rough estimate or require collecting a patient’s urine samples over a 24-hour period.
Stryker Corp. (NYSE:SYK) expanded the number of seats on its board of directors to nine with the addition of the CEO of Belgian biopharm firm Roch Doliveux.
Kalamazoo, Mich.-based Stryker said Doliveux, UCB’s CEO and executive committee chairman since 2005, is the former CEO of Pierre Fabre Pharmaceuticals and former president of Schering-Plough International.
The largest individual shareholder of Charles River Laboratories International Inc. (NYSE:CRL) has deep reservations about the company’s proposed acquisition of WuXi (Cayman) PharmaTech Inc. (NYSE:WX) and they’re not shy letting their position be known.
United BioSource Corp. bought Lexington, Mass.-based life sciences consultancy Abt Bio-Pharma Solutions Inc. for an undisclosed amount.
The Abt Associates subsidiary provides health economics and outcomes research, registries and observational studies and market access solutions to the medical device, biopharmaceutical and diagnostics industries.
